Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zoetis (NY:ZTS)

120.08 +2.22 (+1.88%)
Official Closing Price Updated: 4:10 PM EDT, Apr 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
2 Oversold Stocks Primed to Rebound and 1 Facing Challenges
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
News headline image
How Do Investors Really Feel About Zoetis? ↗
 
Via Benzinga
News headline image
Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results
From Zoetis Inc.
Via Business Wire
News headline image
Analyst Expectations For Zoetis's Future ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
How Do Investors Really Feel About Zoetis? ↗
 
Via Benzinga
News headline image
Zoetis Inc (NYSE:ZTS) Demonstrates Strong Quality Investing Traits in Caviar Cruise Screen ↗
Zoetis (ZTS) excels in quality investing with strong revenue growth, a high 48% ROIC, and solid cash flow. Its financial health meets strict Caviar Cruise screening standards for long-term value. 
Via Chartmill
News headline image
1 S&P 500 Stock Worth Investigating and 2 Facing Headwinds
While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural... 
Via StockStory
Topics Stocks
News headline image
Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats
From Zoetis Inc.
Via Business Wire
News headline image
1 Cash-Producing Stock to Consider Right Now and 2 That Underwhelm
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
From Zoetis Inc.
Via Business Wire
News headline image
2 Reasons to Watch ZTS and 1 to Stay Cautious
Over the past six months, Zoetis’s shares (currently trading at $156.80) have posted a disappointing 7% loss, well below the S&P 500’s 8.6% gain. This might have investors contemplating their next... 
Via StockStory
Topics Government Stocks World Trade
News headline image
Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q2, starting with... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises
Animal health company Zoetis (NYSE:ZTS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue to be around... 
Via StockStory
News headline image
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever ↗
Dip into a beaten-down market sector for deals on some proven winners. 
Via The Motley Fool
News headline image
Zoetis Announces Pricing of $1.85 Billion of Senior Notes
From Zoetis Inc.
Via Business Wire
News headline image
If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today ↗
The short-term picture has been less rosy than the longer-term one. 
Via The Motley Fool
News headline image
3 Large-Cap Stocks with Promising Prospects
Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth... 
Via StockStory
News headline image
2 Stocks to Buy With $5,000 and Hold for a Decade ↗
These two stocks come from completely different industries, but each could boost a long-term investor's returns. 
Via The Motley Fool
News headline image
Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline ↗
Zoetis beats Q2 estimates with strong pet product sales and raises full-year guidance despite livestock sales decline and Librela weakness. 
Via Benzinga
News headline image
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday? ↗
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. 
Via Benzinga
Topics Economy Government
News headline image
Zoetis Surges After Crushing Expectations And Raising Its Outlook ↗
The company raised its adjusted profit guidance by 10 cents at the midpoint and hiked its sales guide by $25 million. 
Via Investor's Business Daily
News headline image
Discover the top S&P500 movers in Tuesday's pre-market session. ↗
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
News headline image
Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue... 
Via StockStory
News headline image
1 Top Dividend Growth Stock to Buy and Hold Forever ↗
The demand for this company's products will continue increasing. 
Via The Motley Fool
News headline image
Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook
From Zoetis Inc.
Via Business Wire
News headline image
IDEXX Laboratories Soars: A New Benchmark for Animal Health Diagnostics
IDEXX Laboratories (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, has sent ripples through the financial markets with an astounding 27.5% surge in its stock price. This... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
Zoetis (ZTS) Reports Earnings Tomorrow: What To Expect
Animal health company Zoetis (NYSE:ZTS) will be announcing earnings results this Tuesday morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
Billionaire Terry Smith Sold Fundsmith's Entire Stake in Apple and 11X'd His Position in a Company Whose Addressable Market Can Hit $149 Billion by 2032 ↗
The "Warren Buffett of Britain" dumped Buffett's actual No. 1 holding in favor a stock with the legs to run higher. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.